Abstract:
(PCa), which is the second most common malignancy and the fifth leading cause of cancer 48 death in men worldwide [6] . In most European countries such as France, The Netherlands, and 49 the Czech Republic, the PCa incidence increased significantly in the early 1990s, and is still 50 increasing [7, 8] . reported an amperometric assay for the measurement of miRNAs with a detection limit of 80 Nevertheless, the above electrochemical methods are based on relatively complex and tedious 81 sensor surface preparation with immobilised oligonucleotide capture probe, and require 82 multiple hybridisation steps. 83 In the present work, we report the development of a robust neutravidin based biosensor for 
Preparation of biotin-MB-AuNP biolabel

142
The biotin-MB-AuNP conjugate was synthesised in accordance with a previously published Figure 1A shows that the signal response increased with increasing time.
228
Therefore, 180 min was chosen as the preferred time, since it proved a good compromise 229 between the assay time and the signal response.
230
Keeping the frequency as 20 Hz and the time of pretreatment as 180 s, the optimum AuNPs further increased from 3.12 to 3.68 mg/mL, the peak current decreased slightly,
242
probably due to the use of higher concentrations of the biotin-MB-AuNPs, which seems to have 243 a saturation effect on the signal response [22, 25] . Subsequently, 3.12 mg/mL of the biotin-MB-
244
AuNP was used as the optimised concentration. (Figure 1C ).
245
To define the nature of the capturing layer, optimisation of the amount of neutravidin on Au ions. The modified GCE displayed a well-defined response at +0.84 V vs Ag/AgCl to Au 3+ .
263
The detection peak corresponded to the reduction of the Au 3+ to Au 0 on the surface of GCE.
264
The SSWV peak currents rose significantly with increasing concentrations of target replicates. The coefficients of variation for both measured concentrations were 4.2% and 5.5%, 271 respectively ( Figure S1 ). Thus, the biosensor displayed high sensitivity and acceptable 272 reproducibility, and could be applied to quantification of miRNA-21 at low concentrations.
273
The selectivity of the biosensor was evaluated by analysing closely related miRNAs the AuNPs. Subsequently, silver deposition time followed by voltammetric detection were 295 optimised in order to maximise the sensitivity and to shorten the assay time. Figure 4 shows the 296 effect of the silver deposition time on the SSWV signal response for 0.5×10 -9 M of miRNA-21.
297
The peak current signal increased against the silver deposition time of 2 to 12 min. Ten minutes 298 was chosen as the preferred time since it proved a good compromise between the silver 299 deposition time and the signal response.
300
The analytical performance of the silver enhanced miRNA biosensors was investigated by 301 varying the target miRNA-21 concentration. After the silver enhancement step, the electrode 
305
Immediately after the electrochemical oxidation step, striping square wave voltammetry 306 (SSWV) was performed. During this step the potential was scanned from 0 to 0.8 V (step 307 potential = 10 mV, frequency = 20 Hz), resulting in an analytical signal due to the oxidation of 308 Ag 1+ . The modified GCE displayed a well-defined response at +0.27 V vs. Ag/AgCl to Ag 1+ .
309
The detection peak corresponded to the oxidation of the Ag 1+ to Ag 2+ on the surface of GCE.
310
Experiments showed that the signal obtained from the oxidation peak current of silver could 
319
A selectivity study of the biosensor was performed after silver enhancement by analysing signal fitted to the calibration curve in Figure 5 to calculate an approximate concentration value.
334
After this, solutions containing approximately twice and three times the calculated preliminary Table 1 and the correlation plot (measured concentration using the standard 341 addition method vs the actual concentration) is shown in Figure 7 . As it can be seen from Table   342 1 and Figure 
